CHRISTIAN GUSSNER: Open Payments
NPI 1063498954 · MERIDIAN, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$597 in 27 payments from 9 companies in 2025. Trend: 2023 $425 · 2024 $987 · 2025 $597
Food & beverage: $597
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $174 |
| Boston Scientific Corporation | 6 | $157 |
| Ipsen Biopharmaceuticals, Inc | 3 | $71 |
| Averitas Pharma Inc. | 2 | $58 |
| SPINEFRONTIER, INC. | 2 | $44 |
| ITF Therapeutics LLC | 1 | $33 |
| Stryker Corporation | 1 | $25 |
| PIRAMAL CRITICAL CARE | 1 | $18 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $17 |
Products named: Intracept, Dysport, General - Pain Management, UBRELVY, BOTOX, QUTENZA, QULIPTA, Inspan.
Industry payments across ID — which companies pay providers there.
